Molecular characterization of extended-spectrum β-lactamases-producing Escherichia coli and Klebsiella pneumoniae in hospitals of the Caribean Region, Colombia;Caracterización molecular de Escherichia coli y Klebsiella pneumoniae productores de β-lactamasas de espectro extendido en hospitales de la Región Caribe, Colombia

Revista Chilena de Infectologia

Volumn 26, Issue 3, 2009, Pages 239-246

  Gaitán C , Sandra L ^a   Espinal M , Paula A ^a  

^a UNIVERSIDAD DEL SINÚ   (Colombia)

Author keywords

lactamases; Colombia; ESBL; Escherichia coli; Klebsiella pneumoniae

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; BIOSYNTHESIS; COLOMBIA; DRUG EFFECT; ENZYMOLOGY; ESCHERICHIA COLI; GENETICS; GENOTYPE; HUMAN; ISOELECTRIC FOCUSING; KLEBSIELLA PNEUMONIAE; MICROBIOLOGICAL EXAMINATION; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; COLOMBIA; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; GENOTYPE; HUMANS; ISOELECTRIC FOCUSING; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION;

EID: 67749097516     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Paterson D, Hujer K, Hujer A, Yeiser B, Bonomo M, Rice L, et al. Extendedspectrum β-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: Dominance and widespread prevalence of SHV- and CTX-M-type β-lactamases. Antimicrob Agents Chemother 2003; 47 (11): 3554-60.
2. Kim J, Lim Y, Jeong Y, Seol S. Ocurrence of CTX-M-3, CTX-M-15, CTX-M-14 and CTX-M-9 extended-spectrum β-lactamases in Enterobacteriaceae Clinical isolates in Korea. Antimicrob Agents Chemother 2005; 49 (4): 1572-5.
3. st century: characterization, epidemiology, and detection of this important resistance in vitro. Clin Microbiol Rev 2001; 14: 933-51.
4. Schwaber M J, Navon-Venezia S, Schwartz D, Carmeli Y. High levels of antimicrobial coresistance among extended spectrum β-lactamase producing Enterobacteriaceae. Antimicrob Agents Chemother 2005; 49: 2137-9.
5. Gales C, Jones R, Gordon K, Sader H, Wilke W, Beach M. Activity and spectrum of antimicrobial agents tested again urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program. J Antimicrob Chemother 1998; 45: 295-303.
6. Villegas M V, Correa A, Pérez F, Miranda M C, Zuluaga T, Quinn J P, et al. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals. Diagn Microbiol Infect Dis 2004; 49: 217-22.
7. Villegas M V, Correa A, Pérez F, Zuluaga T, Radice M, Gutkind G, et al. CTX-M-12 betalactamase in a Klebsiella pneumoniae clinical isolate in Colombia. Antimicrob Agents Chemother 2004; 48: 629-31.
8. th informational supplement.
9. Yong D, Lee K, Yum J H, Shin H B, Rossolini G M, Chong Y. Imipenem-EDTA disk method for differentiation of metallo- β-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2002; 40: 3798-801.
10. Lee K, Lim Y S, Yong D, Yum J H, Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-β-lactamase producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2003; 41: 4623-9.
11. Hemalatha V, Sekar U, Kamat V. Detection of metallo-betalactamase producing Pseudomonas aeruginosa in hospitalized Indian patients. J Med Res 2005; 122: 148-52.
12. Mathew M, Harris A, Marshall M, Ross G. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J General Microbiol 1975; 88: 169-78.
13. Pitout J, Hossain A, Hanson N. Phenotypic and molecular detection of CTX-M-β- lactamases produced by Escherichia coli and Klebsiella spp. J Clin Microbiol 2004; 42: 5715-21.
14. Miranda G, Kelly C, Solorzano F, Leanos B, Coria R, Paterson J. Use of pulsed-field gel electrophoresis typing to study an outbreak of infection due to Serratia marcescens in a neonatal intensive care unit. J Clin Microbiol. 1996; 34 (12): 3138-41.
15. Tenover F, Arbeit R, Goering R, Mickelsen P, Murray B, Persing D, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed field gel electrophoresis: Criteria for bacterial strain typing. J Clin Microbiol 1995; 33 (9): 2233-9.
16. Luzzaro F, Mezzatesta M, Mugnaioli C, Perilli M, Stefani S, Amicosante G, et al. Trends in production of extended-spectrum β-lactamases among enterobacteria of medical interest: Report of the Second Italian Nationwide Survey. J Clin Microbiol 2006; 44 (5): 1659-64.
17. Edelstein M, Pimkin M, Palagin I, Edelstein I, Stratchounski L. Prevalence and molecular epidemiology of CTX-M extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother 2003; 47 (12): 3724-52.
18. Giamarellou H. Multidrug resistance in Gram-negative bacteria that produce extended-spectrum β-lactamases (ESBLs). Clin Microbiol Infect 2005; 11 (Suppl 4): 1-16.
19. Schwaber M J, Navon-Venezia S, Schwartz D, Carmeli Y. High levels of antimicrobial coresistance among extendedspectrum- β-lactamase producing Enterobacteriaceae. Antimicrob Agents Chemother 2005; 49: 2137-9.
20. th Interscience Conference on Antimicrob Agents and Chemotherapy (ICAAC). American Society for Microbiology Washington 2005; Abstract LB2-20.
21. Eisner A, Fagan E, Feierl G, Kessler H, Marth E, Livermore D, Woodford N. Emergence of Enterobacteriaceae isolates producing CTX-M extended-spectrum β-lactamase in Austria. Antimicrob Agents Chemother 2006; 50 (2): 785-7.
22. Cirz R, Romesberg F. Induction and inhibition of ciprofloxacin resistanceconferring mutations in hypermutator bacteria. Antimicrob Agents Chemother 2006; 50 (1): 220-5.
23. Tenover F, Raney P, Williams P, Rasheed K, Biddle J, Oliver A, et al. Evaluation of the NCCLS extendedspectrum β-lactamase confirmation methods for Escherichiria coli with isolates collected during Project ICARE. J Clin Microbiol 2003; 41 (7): 3142-6.
24. Spanu T, Luzzaro F, Perilli M, Amicosante G, Toniolo A, Fadda G, et al. Occurrence of extended-spectrum β-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to β-lactams and other antimicrobial drugs. Antimicrob Agents Chemother 2002; 46: 196-202.
25. Hernández J, Martínez L, Canton R, Coque T, Pascual A. Diversity of extendedspectrum beta-lactamases (ESBL) among E. coli and K. pneumoniae in a Nationwide Study in Spain. Program and Abstracts of 43th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Chicago 2003; abstr C2-57.
26. th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Chicago 2003; abstr C2-49.
27. Smith E, Geun S, Thomson K, Larone D, Hanson N. Letters to Editor. Klebsiella pneumoniae isolate producing at least eight different β-lactamases, including AmpC and KPC β-lactamases. Antimicrob Agents Chemother 2007; 51 (2): 800-1.
28. th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco. 2006. Abstr C2-98.
29. Mantilla J, Reguero M, González E, García I, Leal A, Espinal P, et al. Caracterización molecular de un brote por Klebsiella pneumoniae productora de CTX-M-12 en la unidad de cuidado intensivo neonatal de un hospital colombiano. Biomédica 2006; 26: 408-14.
30. Villegas M, Correa A, Pérez F, Zuluaga T, Radice M, Gutkind G, et al. The Colombian Nosocomial Resistance Study Group. CTX-M-12 β-lactamase in a Klebsiella pneumoniae clinical isolate in Colombia. Antimicrob Agents Chemother 2004; 48: 629-31.
31. Mugnaioli C, Luzzaro F, De Luca F, Brigante G, Perilli M, Amicosante G, et al. CTX-M-type extended-spectrum β-lactamases in Italy: Molecular epidemiology of an emerging countrywide problem. Antimicrob Agents Chemother 2006; 50 (6): 2700-6.
32. Robin F, Delmas J, Archambaud M, Schweitzer C, Chanal C, Bonnet R. CMT-type β-lactamase TEM-125, an emerging problem for extended-spectrum β-lactamase detection. Antimicrob Agents Chemother 2006; 50 (7): 2403-8.
33. Yan J, Hsueh P, Lu J, Chang F, Shyr J, Wan J, et al. Extended-spectrum β-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan. Antimicrob Agents Chemother 2006; 50 (6): 1861-4.
34. Schmidtke A, Hanson N. Model system to evaluate the effect of ampD mutations on AmpC-mediated β-lactam resistance. Antimicrob Agents Chemother 2006; 50 (6): 2030-7.